Consistent with our expectations, both IFN-γ immunocytokines – but not an isotype control antibody - labeled all four ATCC cell lines equivalently and robustly (Fig. 4C) These results demonstrate that IFN-γ immunocytokines are capable of binding CD70 on the surface of human RCC cells. Here, CD70 is linked to renal cell carcinoma.